Drug profile · INN
ramosetron hydrochloride
IRRIBOW
ramosetron hydrochloride (IRRIBOW) is a serotonin 3 (5-ht3) receptor antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ramosetron hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.78
Quick answer
ramosetron hydrochloride (IRRIBOW) is a serotonin 3 (5-ht3) receptor antagonist.
Key facts
INN ramosetron hydrochloride
Brand IRRIBOW
Mechanism Serotonin 3 (5-HT3) receptor antagonist
Target Serotonin 3 (5-HT3) receptor
Mechanism of action
Serotonin 3 (5-HT3) receptor antagonist
Primary target: Serotonin 3 (5-HT3) receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is ramosetron hydrochloride?
ramosetron hydrochloride (IRRIBOW) is a serotonin 3 (5-ht3) receptor antagonist.
What is the brand name for ramosetron hydrochloride?
IRRIBOW is a marketed brand name for ramosetron hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.